A14516990
15 Amendments of the Terms and Conditions
15.1 The Agent may, on account of the Holders, agree with the Company to amend these Terms and Conditions as long as such amendment does not limit the obligation of the Company to pay any amounts in relation to principal or interest or in any other way, to the Agents discretion, may materially adversely affect the interests of the Holders or that such amendment is made solely with a view to rectify obvious errors and mistakes in these Terms and Conditions. Subject to decisions of the Holders in accordance with Section 14 (The Agent's right to represent the Holders, Holder's meeting etc.), the Agent may also agree with the Company regarding other amendments.
15.2
When the Bonds are listed on NASDAQ OMX, the Agent may, on account of the Holders, agree with the Company to make necessary amendments to these Terms and Conditions to ensure that they comply with any requirements for listing, as long as such amendments do not materially adversely affect the interests of the Holders.
15.3
Amendments of these Terms and Conditions shall be notified without delay by the Company in accordance with Section 18 (Notices), setting out the date from which the amendments will be effective.
16 Prescription
16.1 The right to receive payment of the Nominal Amount shall be prescribed and become void ten (10) years from the Final Redemption Date. The right to receive payment of interest shall be limited and become void three (3) years from the relevant due date for payment. The Company is entitled to any funds set aside for payments in respect of which the Holders right to receive payment has been limited and void.
